# Alopexx

> Alopexx is a VC fund in Concord backing Health Care and Therapeutics. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Concord, United States
- Total investments: 1
- Last investment: Sep 2014
- Lead investor: 100%
- Last updated: Aug 2026
- Website: http://www.alopexx.com/

Alopexx is a VC fund in Concord focused on Health Care and Therapeutics. Alopexx partners with innovative entrepreneurs to build successful new companies. We will in-license novel therapies or medical devices

## Contacts

5 contacts available for Alopexx. Shizune tracks 1 team members at Alopexx. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/alopexx-enterprises?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Daniel Vlock | Founder and CEO; Chief Medical Officer; Chief Medical Officer; CEO of Alopexx Pharmaceuticals | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cognoptix | Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.The company was founded in 2001 and headquarteredin Marlborough, Massachusetts. | $15M | Series D | Sep 30, 2014 |  |

1 of 1 investments shown.

## Co-investors
- [Inventages Venture Capital Investment Inc.](https://shizune.co/investors/profile/inventages-venture-capital-investment-inc) — VC Fund, 1 deal together
- [LaunchPad Venture](https://shizune.co/investors/profile/launchpad-venture-group) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sigma Partners](https://shizune.co/investors/profile/sigma-partners) — VC Fund
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund
- [Trifecta Capital Advisors](https://shizune.co/investors/profile/trifecta-capital-advisors) — VC Fund

## FAQ

### What does Alopexx invest in?

Alopexx invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Alopexx?

Public channels for Alopexx include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Alopexx?

The team at Alopexx includes Daniel Vlock (Founder and CEO; Chief Medical Officer; Chief Medical Officer; CEO of Alopexx Pharmaceuticals). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co